Published in J Clin Oncol on October 01, 2007
Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys (2013) 0.95
Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer (2010) 0.88
Merkel cell carcinoma of skin-current controversies and recommendations. Rare Tumors (2011) 0.80
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
Diagnosis and management of mycosis fungoides. Oncology (Williston Park) (2010) 2.32
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Factors that determine academic versus private practice career interest in radiation oncology residents in the United States: results of a nationwide survey. Int J Radiat Oncol Biol Phys (2013) 1.97
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol (2010) 1.96
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol (2012) 1.84
The pathogenesis of mycosis fungoides. N Engl J Med (2004) 1.78
Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leuk Lymphoma (2006) 1.72
Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol (2011) 1.71
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol (2007) 1.70
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Management of mycosis fungoides: Part 2. Treatment. Oncology (Williston Park) (2003) 1.57
The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol (2005) 1.57
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer J (2007) 1.46
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys (2005) 1.44
Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials. Cancer J (2006) 1.41
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J (2004) 1.39
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol (2002) 1.29
The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol (2010) 1.20
Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16
Total skin electron beam radiotherapy for patients who have mycosis fungoides. Hematol Oncol Clin North Am (2003) 1.13
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys (2007) 1.11
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (2012) 1.06
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma. Arch Dermatol (2009) 1.06
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol (2004) 1.02
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. Int J Radiat Oncol Biol Phys (2005) 1.01
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol (2008) 0.97
Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys (2011) 0.96
Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol (2015) 0.94
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol (2010) 0.94
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res (2013) 0.93
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med (2014) 0.93
Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92
Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer (2012) 0.91
Cutaneous lymphoma. Curr Probl Cancer (2008) 0.91
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.91
Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys (2011) 0.91
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.90
Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex. Am J Clin Oncol (2013) 0.90
Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol (2015) 0.90
Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest (2013) 0.89
Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. J Clin Oncol (2008) 0.89
Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys (2012) 0.88
Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys (2012) 0.87
Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis. Oncology (Williston Park) (2003) 0.87
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys (2006) 0.87
National Residency Matching Program (NRMP) results for radiation oncology: 2011 update. Int J Radiat Oncol Biol Phys (2012) 0.86
Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy. J Clin Oncol (2005) 0.86
A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.85
Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg (2013) 0.85
Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res (2004) 0.85
National residency matching program results for radiation oncology: 2012 update. Int J Radiat Oncol Biol Phys (2013) 0.85
A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys (2010) 0.84
Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) (2005) 0.83
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol (2013) 0.83
Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs. Brachytherapy (2013) 0.82
Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy. Int J Radiat Oncol Biol Phys (2004) 0.82
Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors. Cancer J (2006) 0.82
Cutaneous lymphomas. Semin Radiat Oncol (2007) 0.82
A significant decrease in rectal volume and diameter during prostate IMRT. Radiother Oncol (2011) 0.82
Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J (2004) 0.82
Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study. Am J Clin Oncol (2009) 0.82
Advances in radiotherapy for lung cancer. Semin Respir Crit Care Med (2008) 0.82
The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis. J Thorac Oncol (2010) 0.82
Total skin electron beam therapy and cutaneous T-cell lymphoma: a clinical guide for patients and staff. Dermatol Nurs (2004) 0.81
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer. Int J Radiat Oncol Biol Phys (2008) 0.81
Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg (2012) 0.81
Evaluation and treatment of high-risk patients with early-stage lung cancer. Clin Chest Med (2011) 0.80
Postoperative radiation therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg (2008) 0.80
Disseminated herpes simplex after total skin electron beam radiotherapy for mycosis fungoides. J R Soc Med (2003) 0.80
Stage I Lung SBRT Clinical Practice Patterns. Am J Clin Oncol (2017) 0.80
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer. Am J Clin Oncol (2013) 0.80
Unmet challenges in the use of novel agents in locally advanced non-small-cell lung cancer. J Clin Oncol (2012) 0.79
Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer. Head Neck (2012) 0.79
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature. Leuk Lymphoma (2015) 0.79
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer (2010) 0.79
Radiotherapy for thymoma and thymic carcinoma. Hematol Oncol Clin North Am (2008) 0.79